Indeed. The opportunity cost has been enormous though. Back on topic, it will be nice to see some brokers get bullish and update their price targets now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025